CNTA - Centessa Pharmaceuticals plc

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 440.62M
Enterprise value 116.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.31
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.57

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 344.27%
S&P500 52-week change 32.74%
52-week high 36.0900
52-week low 32.8850
50-day moving average 34.3284
200-day moving average 33.9392

Share statistics

Avg vol (3-month) 3144.69k
Avg vol (10-day) 3106.07k
Shares outstanding 595.61M
Implied shares outstanding 6N/A
Float 820.11M
% held by insiders 11.86%
% held by institutions 177.05%
Shares short (14 May 2023) 41.7M
Short ratio (14 May 2023) 410.88
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 41.77%
Shares short (prior month 13 Apr 2023) 41.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-25.98%
Return on equity (ttm)-54.93%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -204.78M
Net income avi to common (ttm)-212.42M
Diluted EPS (ttm)-2.3100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)346.23M
Total cash per share (mrq)3.64
Total debt (mrq)81.31M
Total debt/equity (mrq)27.73
Current ratio (mrq)12.95
Book value per share (mrq)3.08

Cash flow statement

Operating cash flow (ttm)-198.37M
Levered free cash flow (ttm)-106.63M